Terms: = Liver cancer AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E AND Treatment
87 results:
1. FGF19 and its analog Aldafermin cooperate with MYC to induce aggressive hepatocarcinogenesis.
Ursic-Bedoya J; Desandré G; Chavey C; Marie P; Polizzi A; Rivière B; Guillou H; Assenat E; Hibner U; Gregoire D
EMBO Mol Med; 2024 Feb; 16(2):238-250. PubMed ID: 38228803
[TBL] [Abstract] [Full Text] [Related]
2. FAT4 loss initiates hepatocarcinogenesis through the switching of canonical to noncanonical WNT signaling pathways.
Huang FY; Wong DK; Mak LY; Cheung TT; Zhang SS; Chau HT; Hui RW; Seto WK; Yuen MF
Hepatol Commun; 2023 Dec; 7(12):. PubMed ID: 38055646
[TBL] [Abstract] [Full Text] [Related]
3. Deep learning models for automatic tumor segmentation and total tumor volume assessment in patients with colorectal liver metastases.
Wesdorp NJ; Zeeuw JM; Postma SCJ; Roor J; van Waesberghe JHTM; van den Bergh JE; Nota IM; Moos S; Kemna R; Vadakkumpadan F; Ambrozic C; van Dieren S; van Amerongen MJ; Chapelle T; Engelbrecht MRW; Gerhards MF; Grunhagen D; van Gulik TM; Hermans JJ; de Jong KP; Klaase JM; Liem MSL; van Lienden KP; Molenaar IQ; Patijn GA; Rijken AM; Ruers TM; Verhoef C; de Wilt JHW; Marquering HA; Stoker J; Swijnenburg RJ; Punt CJA; Huiskens J; Kazemier G
Eur Radiol Exp; 2023 Dec; 7(1):75. PubMed ID: 38038829
[TBL] [Abstract] [Full Text] [Related]
4. The Molecular, Immunologic, and Clinicodemographic Landscape of MYC-Amplified Advanced Prostate cancer.
Jin WH; Zhang L; Graf R; Raskina K; Tukachinsky H; Huang RSP; McGregor K; Alshalalfa M; Hougen HY; Khan A; Punnen S; Schrock AB; Venstrom J; Mahal BA
Clin Genitourin Cancer; 2024 Feb; 22(1):e163-e169.e1. PubMed ID: 37978032
[TBL] [Abstract] [Full Text] [Related]
5. Modified Bushen Yiqi formula enhances antitumor immunity by reducing the chemotactic recruitment of M2-TAMs and PMN-MDSCs in Lewis lung cancer-bearing mice.
Kong Q; Zhu H; Gong W; Deng X; Liu B; Dong J
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117183. PubMed ID: 37739106
[TBL] [Abstract] [Full Text] [Related]
6. Yiqi Huayu Jiedu Decoction inhibits liver metastasis of colorectal cancer via enhancing natural killer cells function.
Zhou JY; Wu C; Shen Z; Liu S; Zou X; Qian J; Wu Z; Huan X; Mu BX; Ye N; Ning Y; Wang Y; Chen M; Zhuang Y
J Ethnopharmacol; 2024 Jan; 318(Pt A):116915. PubMed ID: 37451487
[TBL] [Abstract] [Full Text] [Related]
7. CSNK2A2 promotes hepatocellular carcinoma progression through activation of NF-κB pathway.
Yang S; Peng LR; Yu AQ; Li J
Ann Hepatol; 2023; 28(5):101118. PubMed ID: 37268061
[TBL] [Abstract] [Full Text] [Related]
8. Splenectomy and azygoportal disconnection decreases the risk of hepatocellular carcinoma for cirrhosis patients with portal hypertension bleeding: a 10-year retrospective follow-up study based on the inverse probability of treatment weighting method.
Gao TM; Zhou J; Xiang XX; Jin SJ; Qian JJ; Zhang C; Zhou BH; Tang H; Bai DS; Jiang GQ
J Gastroenterol; 2023 May; 58(5):503-512. PubMed ID: 36943530
[TBL] [Abstract] [Full Text] [Related]
9. Serum metabolomics reveals the effects of accompanying treatment on fatigue in patients with multiple myeloma.
Zhang HT; Xiong H; Xiao HW; Zhang ZH; Huang CL; Huang MZ
Support Care Cancer; 2022 Dec; 31(1):43. PubMed ID: 36525141
[TBL] [Abstract] [Full Text] [Related]
10. Real-time image-guided treatment of mobile tumors in proton therapy by a library of treatment plans: a simulation study.
Hamaide V; Souris K; Dasnoy D; Glineur F; Macq B
Med Phys; 2023 Jan; 50(1):465-479. PubMed ID: 36345808
[TBL] [Abstract] [Full Text] [Related]
11. Silencing of KNTC1 inhibits hepatocellular carcinoma cells progression via suppressing PI3K/Akt pathway.
Tong H; Liu X; Peng C; Shen B; Zhu Z
Cell Signal; 2023 Jan; 101():110498. PubMed ID: 36273753
[TBL] [Abstract] [Full Text] [Related]
12. LiSNet: An artificial intelligence -based tool for liver imaging staging of hepatocellular carcinoma aggressiveness.
Sun SW; Xu X; Liu QP; Chen JN; Zhu FP; Liu XS; Zhang YD; Wang J
Med Phys; 2022 Nov; 49(11):6903-6913. PubMed ID: 36134900
[TBL] [Abstract] [Full Text] [Related]
13. The Potential Predictive Biomarkers for Advanced Hepatocellular Carcinoma Treated With Anti-Angiogenic Drugs in Combination With PD-1 Antibody.
Liu C; Zhu S; Dong Y; Shao J; Liu B; Shen J
Front Immunol; 2022; 13():930096. PubMed ID: 35874743
[TBL] [Abstract] [Full Text] [Related]
14. Arecoline promotes proliferation and migration of human HepG2 cells through activation of the PI3K/AKT/mTOR pathway.
Xie H; Jing R; Liao X; Chen H; Xie X; Dai H; Pan L
Hereditas; 2022 Jul; 159(1):29. PubMed ID: 35836300
[TBL] [Abstract] [Full Text] [Related]
15. Estimation of iron overload with T2*MRI in children treated for hematological malignancies.
Munikoty V; Sodhi KS; Bhatia A; Bhatia P; Verma Attri S; Rohit MK; Trehan A; Khandelwal N; Bansal D
Pediatr Hematol Oncol; 2023 May; 40(4):315-325. PubMed ID: 35833695
[TBL] [Abstract] [Full Text] [Related]
16. Clinical implications and biological features of a novel postoperative recurrent HCC classification: A multi-centre study.
Qi LN; Ma L; Wu FX; Chen YY; Xu JX; Peng YC; Chen ZS; Gong WF; Yang CL; Wei HW; Qin SL; Shang JJ; Wang QY; Yu HP; Peng T; Huang YW; Ling YC; Tang WZ; Xiang BD; Li LQ
Liver Int; 2022 Oct; 42(10):2283-2298. PubMed ID: 35810457
[TBL] [Abstract] [Full Text] [Related]
17. Network Pharmacology-Based Strategy to Investigate the Mechanisms of Lenvatinib in the treatment of Hepatocellular Carcinoma.
Liu P; Han B; Zhang Y; Wang X
Comput Intell Neurosci; 2022; 2022():7102500. PubMed ID: 35720901
[TBL] [Abstract] [Full Text] [Related]
18. Cell division cycle associated 2 (CDCA2) upregulation promotes the progression of hepatocellular carcinoma in a p53-dependant manner.
Wang J; Liu X; Chu H; Chen J
PeerJ; 2022; 10():e13535. PubMed ID: 35694386
[TBL] [Abstract] [Full Text] [Related]
19. Tenofovir vs. entecavir on recurrence of hepatitis B virus-related hepatocellular carcinoma beyond Milan criteria after hepatectomy.
Shen J; Qi W; Dai J; Leng S; Jiang K; Zhang Y; Ran S; Li C; Wen T
Chin Med J (Engl); 2021 Dec; 135(3):301-308. PubMed ID: 34958539
[TBL] [Abstract] [Full Text] [Related]
20. Diosmetin inhibits cell growth and proliferation by regulating the cell cycle and lipid metabolism pathway in hepatocellular carcinoma.
Pan L; Feng F; Wu J; Li L; Xu H; Yang L; Xu K; Wang C
Food Funct; 2021 Nov; 12(23):12036-12046. PubMed ID: 34755740
[TBL] [Abstract] [Full Text] [Related]
[Next]
